PRECURSOR STEM CELL TECHNOLOGIES INC. Successful Results of Autologous Precursor Stem Cell Therapy for IDDM patients have been reported as: Pre-proliferative stage of diabetic retinopathy Pre-azotemic stage of diabetic nephropathy Any stage of diabetic poly-neuropathy Pre-obstructive stage of diabetic vasculopathy Clinically uncontrollable children’ s ‘brittle diabetes’ 65% 60% 95% 70% 90% DIABETES MELLITUS Saving lives: PSC T Autologous Pr ecursor Stem Cell T herapy Warning: All designs, materials, images and photos are for promotion of PSCT products only and may not be further reproduced or stored electronically without written permission from the licence holder. Copyright © 2010 PSCT Inc. Unauthorised reproduction, even partial, is strictly forbidden and may result in serious nancial and other penalties. Clinical experience of the past few decades have shown only Autologous Precursor Stem Cell Therapy can stop the relentless progress of the complications of diabetes mellitus once they start. Diabetes mellitus will frequently reach the stage o f life threatening and severely complicating the progress of which cannot be controlled by insulin alone. It has been known for decades that stem cell therapy is the sole therapy available for such advanced stages of diabetes. Th ere are published data about several thousands of diabetics that have been handled in clinical practice with ever growing success during the last 70 years. The sooner the patient receives Autologous Precursor Stem Cell Therapy after the diagnosis of diabetic complication is established, the better will be the success rate of the therapy. A number of children with recent onset of diabetes mellitus has been treated successfully with Autologous Precursor Stem Cell Therapy . Autologous Precursor Stem Cell Therapy is able to delay the progression of diabetic complications. If one could postponed the onset of juvenile diabetes by one more year, it would be of tremendous value because of well known deleterious eect of diabetic condition on growth and development of such children. The preparation of stem cells by PSCT proprietary method of primary tissue culture, lowers the immunogenicity of stem cell t herapy to such a degree that no immunosuppression is required and this is of great importance particularly for the treatment of diabetes mellitus. Besides the known side-eects, the specic problem of immune suppression in diabetics is that it causes an increased metabolic demand on ß–cells of pancreatic islets so that their capacity to produce insulin may be exhausted. This deleterious e ect is much greater for islet cell transplants than for organ transplant of pancreas. www.precursorstemcells.com
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
7/29/2019 Diabetes & Stem Cell . Poster.
http://slidepdf.com/reader/full/diabetes-stem-cell-poster 1/1
PRECURSOR STEM CELLTECHNOLOGIES INC.
Successful Results of Autologous Precursor Stem Cell Therapyfor IDDM patients have been reported as:
Pre-proliferative stage of diabetic retinopathy
Pre-azotemic stage of diabetic nephropathy
Any stage of diabetic poly-neuropathy
Pre-obstructive stage of diabetic vasculopathyClinically uncontrollable children’s ‘brittle diabetes’
65%
60%
95%
70%90%
DIABETES
MELLITUSSaving lives:
PSCT Autologous PrecursorStem Cell Therapy
Warning: All designs, materials, images and photos are for promotion of PSCT products only and may not be further reproduced or stored electronically without written permission from the licence holder. Copyright © 2010 PSCT Inc. Unauthorised reproduction, even partial, is strictly forbidden and may result in serious nancial and other penalties.
Clinical experience of the past few
decades have shown only Autologous
Precursor Stem Cell Therapy can stop the
relentless progress of the complicationsof diabetes mellitus once they start.
Diabetes mellitus will frequently reach the stage of life threatening and severely complicating the progress of whichcannot be controlled by insulin alone. It has been known for decades that stem cell therapy is the sole therapy available for
such advanced stages of diabetes. There are published data about several thousands of diabetics that have been handled inclinical practice with ever growing success during the last 70 years. The sooner the patient receives Autologous PrecursorStem Cell Therapy after the diagnosis of diabetic complication is established, the better will be the success rate of the therapy.
A number of children with recent onset of diabetes mellitus has been treated successfully with Autologous Precursor StemCell Therapy. Autologous Precursor Stem Cell Therapy is able to delay the progression of diabetic complications. If one couldpostponed the onset of juvenile diabetes by one more year, it would be of tremendous value because of well known deleteriouseect of diabetic condition on growth and development of such children.
The preparation of stem cells by PSCT proprietary method of primary tissue culture, lowers the
immunogenicity of stem cell therapy to such a degree that no immunosuppression is required
and this is of great importance particularly for the treatment of diabetes mellitus. Besides the
known side-eects, the specic problem of immune suppression in diabetics is that it causes an
increased metabolic demand on ß–cells of pancreatic islets so that their capacity to produce
insulin may be exhausted. This deleterious eect is much greater for islet cell transplants than
for organ transplant of pancreas.
www.precursorstemcells.com
Related Documents
